Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.

Shirai K, Kawashima M, Saitoh JI, Abe T, Fukata K, Shigeta Y, Irie D, Shiba S, Okano N, Ohno T, Nakano T.

PLoS One. 2017 Apr 11;12(4):e0175589. doi: 10.1371/journal.pone.0175589. eCollection 2017.

3.

Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?

Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock DN, Blackstock AW, Hinson WH, Munley MT, Petty WJ, Urbanic JJ.

Cureus. 2016 Jan 23;8(1):e466. doi: 10.7759/cureus.466.

4.

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.

Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J.

Radiat Oncol. 2016 Feb 5;11:18. doi: 10.1186/s13014-016-0589-7. Review.

5.

Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients.

Kilburn JM, Soike MH, Lucas JT, Ayala-Peacock D, Blackstock W, Isom S, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ.

Pract Radiat Oncol. 2016 May-Jun;6(3):e73-80. doi: 10.1016/j.prro.2015.10.004. Epub 2015 Oct 22.

7.

A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients.

Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, Belderbos J, Dingemans AM, Rimner A, Din S, Lambin P.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):935-44. doi: 10.1016/j.ijrobp.2015.02.048. Epub 2015 Apr 30.

8.

Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.

Kesarwala AH, Ko CJ, Ning H, Xanthopoulos E, Haglund KE, O'Meara WP, Simone CB 2nd, Rengan R.

Clin Lung Cancer. 2015 May;16(3):237-44. doi: 10.1016/j.cllc.2014.12.001. Epub 2014 Dec 9.

9.

Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.

Chi A, Nguyen NP, Welsh JS, Tse W, Monga M, Oduntan O, Almubarak M, Rogers J, Remick SC, Gius D.

Front Oncol. 2014 Jun 20;4:156. doi: 10.3389/fonc.2014.00156. eCollection 2014. Review.

10.

Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells.

Murata K, Noda SE, Oike T, Takahashi A, Yoshida Y, Suzuki Y, Ohno T, Funayama T, Kobayashi Y, Takahashi T, Nakano T.

J Radiat Res. 2014 Jul;55(4):658-64. doi: 10.1093/jrr/rru002. Epub 2014 Mar 21.

11.

Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study.

Ji K, Zhao LJ, Liu WS, Liu ZY, Yuan ZY, Pang QS, Wang J, Wang P.

Br J Radiol. 2014 Mar;87(1035):20130562. doi: 10.1259/bjr.20130562. Epub 2014 Jan 27.

12.

Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy.

Kang HC, Wu HG, Yu T, Kim HJ, Paeng JC.

Radiat Oncol J. 2013 Sep;31(3):111-7. doi: 10.3857/roj.2013.31.3.111. Epub 2013 Sep 30.

13.

Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes.

Lamb JM, Robinson CG, Bradley JD, Low DA.

Radiother Oncol. 2013 Oct;109(1):112-6. doi: 10.1016/j.radonc.2013.07.015. Epub 2013 Sep 14.

14.

Involved-field radiotherapy versus elective nodal irradiation in combination with concurrent chemotherapy for locally advanced non-small cell lung cancer: a prospective randomized study.

Chen M, Bao Y, Ma HL, Hu X, Wang J, Wang Y, Peng F, Zhou QC, Xie CH.

Biomed Res Int. 2013;2013:371819. doi: 10.1155/2013/371819. Epub 2013 May 13.

15.

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Wurstbauer K, Deutschmann H, Dagn K, Kopp P, Zehentmayr F, Lamprecht B, Porsch P, Wegleitner B, Studnicka M, Sedlmayer F.

Radiat Oncol. 2013 Mar 5;8:49. doi: 10.1186/1748-717X-8-49.

16.

Clinical application of positron emission tomography in designing radiation fields in non-small cell lung cancer patients.

Lin A, Wood C, Hill-Kayser C, Mick R, Kaiser L, Metz J.

Exp Ther Med. 2010 Nov;1(6):1027-1033. Epub 2010 Sep 29.

17.

Measurement of intra-fraction displacement of the mediastinal metastatic lymph nodes using four-dimensional CT in non-small cell lung cancer.

Wang S, Li J, Zhang Y, Wang W, Li F, Fan T, Xu M, Shao Q.

Korean J Radiol. 2012 Jul-Aug;13(4):417-24. doi: 10.3348/kjr.2012.13.4.417. Epub 2012 Jun 18.

18.

Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.

Shirai K, Nakagawa A, Abe T, Kawahara M, Saitoh J, Ohno T, Nakano T.

Int J Mol Imaging. 2012;2012:609545. doi: 10.1155/2012/609545. Epub 2012 May 14.

19.

Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer.

Nichols RC, Huh SH, Hoppe BS, Henderson RH, Li Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP.

Technol Cancer Res Treat. 2011 Aug;10(4):317-22.

20.

Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.

Shirvani SM, Komaki R, Heymach JV, Fossella FV, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e91-7. doi: 10.1016/j.ijrobp.2010.12.072. Epub 2011 Apr 12.

Supplemental Content

Support Center